Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer-Reference-Cited by-同舟云学术

Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer

Published:2024-02 Issue: Volume:188 Page:107442
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Cho Byoung Chul,Chiu Chao-Hua,Massarelli Erminia,Buchschacher Gary L.,Goto Koichi,Overbeck Tobias R.,Loong Herbert H.F.,Chee Cheng E.,Garrido Pilar,Dong Xiaorong,Fan Yun,Lu Shun,Schwemmers Sven,Bordogna Walter,Zeuner Harald,Osborne Stuart,John Thomas^ORCID

Funder

F. Hoffmann-La Roche

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference29 articles.

1. Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study;Mok;Ann. Oncol.,2020

2. Postoperative chemotherapy use and outcomes from ADAURA: osimertinib as adjuvant therapy for resected EGFR-mutated NSCLC;Wu;J. Thorac. Oncol.,2022

3. Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001;Shaw;Ann. Oncol.,2019

4. Updated integrated analysis of the efficacy and safety of entrectinib in patients With NTRK fusion-positive solid tumors;Demetri;Clin. Cancer Res.,2022

5. Clinicopathologic features of non-small-cell lung cancer harboring an NTRK gene fusion;Farago;JCO Precis. Oncol.,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape;Cancer Treatment Reviews;2024-11

2. Current status of molecular diagnostics for lung cancer;Exploration of Targeted Anti-tumor Therapy;2024-06-27

3. The rapidly changing field of predictive biomarkers of non-small cell lung cancer;Pathology and Oncology Research;2024-06-17

4. Inhibition of human UDP-glucuronosyltransferase enzyme by entrectinib: Implications for drug-drug interactions;Chemico-Biological Interactions;2024-05

5. ETV6-NTRK2 Fusion in a Patient With Metastatic Pulmonary Atypical Carcinoid Successfully Treated With Entrectinib: A Case Report and Review of the Literature;Clinical Lung Cancer;2024-05